This inventor holds 2 USPTO granted patents. Top assignee: Jiangsu Alphamab Biopharmaceuticals Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Junfang Xu: Innovator in Tumor Treatment
Introduction
Junfang Xu is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative treatments for tumors. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Junfang Xu holds a patent for a bispecific fusion protein designed for tumor treatment. This innovative approach aims to enhance the efficacy of cancer therapies, providing new hope for patients battling this challenging disease. His patent portfolio reflects his dedication to pioneering solutions in the medical field.
Career Highlights
Currently, Junfang Xu is associated with Jiangsu Alphamab Biopharmaceuticals Co., Ltd. His role at the company allows him to leverage his expertise in biopharmaceutical research and development. His contributions have been instrumental in driving the company's mission to create effective cancer treatments.
Collaborations
Junfang Xu collaborates with talented professionals in his field, including Kangping Guo and Yuhao Jin. These partnerships foster a dynamic environment for innovation and research, enabling the team to tackle complex challenges in tumor treatment.
Conclusion
Junfang Xu's work exemplifies the spirit of innovation in the biopharmaceutical industry. His contributions to tumor treatment through his patented technologies are paving the way for advancements in cancer care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile